Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Malignant Melanoma

Free Subscription 10.08.2026 1 Am J Ophthalmol 1 Ann Surg Oncol 1 BMC Cancer 1 Clin Cancer Res 1 Clin Exp Metastasis 1 J Am Acad Dermatol 1 Melanoma Res 1 Oncogene

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Ophthalmol

1. BELLANDA V, Schulgit MJ, Hassan KA, Kennedy LB, et al
   Immune Checkpoint Inhibitor-Associated Uveitis: Insights from Comparative Analyses Across Malignancies and Drug Classes.
   Am J Ophthalmol. 2026 Jun 1:S0002-9394(26)00298.
   PubMed         Abstract available
   
   

   
   Ann Surg Oncol

2. READ T, Nair G, Velli G, David M, et al
   ASO Visual Abstract: A Systematic Review and Meta-analysis of Surgical Feasibility and Outcomes Following Neoadjuvant Immune Checkpoint Inhibition in Resectable Stage III and IV Melanoma.
   Ann Surg Oncol. 2026 Aug 1. doi: 10.1245/s10434-026-20231.
   PubMed        
   
   

   
   BMC Cancer

3. AWADA A, Tarhini A, Hammoud A, Kassem M, et al
   Hematologic toxicity of immune checkpoint inhibitors: real-world burden and risk profiles from a five-year cohort from the Middle East.
   BMC Cancer. 2026;26:915.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

4. HELGADOTTIR H, Capone M, Ridolfi L, Zambelli A, et al
   Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.
   Clin Cancer Res. 2026 Aug 4. doi: 10.1158/1078-0432.CCR-26-1402.
   PubMed         Abstract available
   
   

   
   Clin Exp Metastasis

5. HEUGENHAUSER J, Herbst S, Drucks T, Scherfler C, et al
   Radiomics for risk stratification in brain metastases: potential in melanoma brain metastases.
   Clin Exp Metastasis. 2026;43:39.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

6. GUNDUZ K, Erol Mart HM, Simsek OF, Ozsan I, et al
   RISK-ADAPTED MONITORING OF MELANOCYTIC LESIONS WITH PERIPHERAL GLOBULES: A LONGITUDINAL COHORT STUDY ON MELANOMA RISK STRATIFICATION.
   J Am Acad Dermatol. 2026 Aug 6:S0190-9622(26)03264.
   PubMed         Abstract available
   
   

   
   Melanoma Res

7. ORLOW I, Luo L, Autuori I, Mina I, et al
   Association of chemokine and chemokine receptor gene variants with occurrence of multiple primary melanoma.
   Melanoma Res. 2026 Aug 4. doi: 10.1097/CMR.0000000000001128.
   PubMed         Abstract available
   
   

   
   Oncogene

8. FU Y, Amiot M, Kuzniak I, Jouenne F, et al
   RAF1 S257L/S259F hotspot mutations: functional characterization and intrinsic resistance to the RAS(ON) inhibitor daraxonrasib in melanoma.
   Oncogene. 2026 Aug 7. doi: 10.1038/s41388-026-03951.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum